COSCIENS Biopharma Inc. (CSCI) Description, Stock price, News & Info.

#ThinkSabio Latest News

COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product